Mutasem Taha

27PUBLICATIONS
38CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesPharmaceutical delivery technologiesBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Nov 04, 2026
Synthesis, in silico studies, and in vitro evaluation of novel isoindigo inhibitors targeting wild-type and D835Y mutant FLT3.

|Aug 12, 2026
Identification of novel PKR inhibitory chemotypes via integrated molecular modelling and machine learning.

|Jul 03, 2026
Hybrid amine-derived compounds as cytotoxic anticancer leads: design, synthesis, and biological evaluation.

|May 22, 2026
Developments in the design and therapeutic applications of GSK3β inhibitors.

|May 04, 2026
Arbutus andrachne Extracts Exhibit In Vitro Neuraminidase (N9) Inhibitory Activity: A Potential Herbal Strategy Against Avian Influenza.

|Apr 27, 2026
Synthesis, and evaluation of novel low nanomolar isoindigo-based RET kinase inhibitors.

Pageof 5

Frequent Collaborators

3 joint publications

Ma'mon M Hatmal

2 joint publications

Areej Abuhammad

2 joint publications

Walhan Alshaer

2 joint publications

Mohammad A I Al-Hatamleh